Serotonin is one of several neurotransmitters which have been established as neuronal-growth regulating substances. As such, serotonin facilitates development in the immature brain, and promotes plasticity in the adult brain. Since a lack of trophic substances has been suggested to play a role in brain aging and age-related diseases, it is likely that serotonergic mechanisms could be important here as well. One mechanism by which serotonin functions as a trophic agent, is by an action on 5-HT1a receptors on astroglial cells. These receptors can stimulate the release of a cortical and serotonergic trophic factor - S-100beta. In recent studies of Alzheimer's Disease, changes in serotonin terminal density, in 5-HT1a receptor number and levels of S-100beta have all been reported. It is clear that an understanding of the factors regulating 5- HT1a receptor release of S-100beta is important to understanding brain aging. The proposed research will study 5-HT1a receptors and S-100beta release in four tissue culture models of astroglial cells, representing different developmental stages. The number of receptors will be studied by autoradiography, using the specific 5-HT1a receptor label 3H-8-OH-DPAT. The amount of S-100beta released, and within the cells, will be determined by radioimmunoassay. The ability of other neurotransmitters and neuromodulators to affect receptor number or S-100beta release will also be studied. Finally, the results derived from tissue culture will be extended into whole animal studies and into post-mortem human tissue.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG010208-02
Application #
3768508
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
New York University
Department
Type
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Mrak, Robert E; Griffin, W Sue T (2005) Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 26:349-54
Sheng, J G; Mrak, R E; Jones, R A et al. (2001) Neuronal DNA damage correlates with overexpression of interleukin-1beta converting enzyme in APPV717F mice. Neurobiol Aging 22:895-902
Nicoll, J A; Mrak, R E; Graham, D I et al. (2000) Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol 47:365-8
Russo, G L; van den Bos , C; Sutton, A et al. (2000) Phosphorylation of Cdc28 and regulation of cell size by the protein kinase CKII in Saccharomyces cerevisiae. Biochem J 351:143-50
Sheng, J G; Zhu, S G; Jones, R A et al. (2000) Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp Neurol 163:388-91
Griffin, W S; Nicoll, J A; Grimaldi, L M et al. (2000) The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk. Exp Gerontol 35:481-7
Zhu, S G; Sheng, J G; Jones, R A et al. (1999) Increased interleukin-1beta converting enzyme expression and activity in Alzheimer disease. J Neuropathol Exp Neurol 58:582-7
Karson, C N; Mrak, R E; Schluterman, K O et al. (1999) Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. Mol Psychiatry 4:39-45
Nishi, M; Azmitia, E C (1999) Agonist- and antagonist-induced plasticity of rat 5-HT1A receptor in hippocampal cell culture. Synapse 31:186-95
Royston, M C; McKenzie, J E; Gentleman, S M et al. (1999) Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition. Neuropathol Appl Neurobiol 25:387-93

Showing the most recent 10 out of 59 publications